Cantor Fitzgerald Reiterates Overweight on Eli Lilly (LLY) Despite Medicare Coverage Risks, Still Sees Clear Path for Coverage Contingent on Successful Phase 3
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 253.31 -1.15 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $254.46 | 52 Week High | $333.65 | |||
| Open | $255.09 | 52 Week Low | $223.02 | |||
| Day High | $255.70 | P/E | 32.43 | |||
| Day Low | $253.00 | EPS | $7.81 | |||
| Volume | 29,353 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1432.06 +14.07 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1417.99 | 52 Week High | $88.16 | |||
| Open | $1435.39 | 52 Week Low | $67.88 | |||
| Day High | $1438.00 | P/E | 331.50 | |||
| Day Low | $1417.72 | EPS | $4.32 | |||
| Volume | 256,322 | |||||
